Skip to search formSkip to main contentSkip to account menu

Minocycline

Known as: (4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide, Minocyclin, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, (4S-(4alpha,4aalpha,5aalpha,12aalpha))- 
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND On the basis of encouraging preliminary results, we conducted a randomized, controlled trial to determine whether… 
Highly Cited
2013
Highly Cited
2013
Objective: Minocycline rescued synaptic abnormalities and improved behavior in the fragile X mouse model. Previous open-label… 
Highly Cited
2006
Highly Cited
2006
Spinal cord injury (SCI) results in loss of oligodendrocytes demyelination of surviving axons and severe functional impairment… 
Highly Cited
2003
Highly Cited
2003
Minocycline has been shown previously to have beneficial effects against ischemia in rats as well as neuroprotective properties… 
Highly Cited
2003
Highly Cited
2003
Objectives: To evaluate the effect of minocycline as treatment for cutaneous calcinosis in limited cutaneous systemic sclerosis… 
Review
1998
Review
1998
The widespread use of broad-spectrum antimicrobial agents poses a significant challenge to bacteria pathogenic for humans, a… 
Highly Cited
1975
Highly Cited
1975
Four tetracyclines were studied in dogs to determine the relation between their lipophilicity and various other pharmacological…